Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 17: 1093-1102, 1971;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roy, A. V.
Right arrow Articles by Hayden, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roy, A. V.
Right arrow Articles by Hayden, J. E.

Clinical Chemistry, Vol 17, 1093-1102, Copyright © 1971 by the American Association for Clinical Chemistry

Sodium Thymolphthalein Monophosphate: A New Acid Phosphatase Substrate with Greater Specificity for the Prostatic Enzyme in Serum

A. V. Roy 1, Mary E. Brower 1, and Jean E. Hayden 1

1 Pathology Department, South Side Hospital, S. 20th and Jane Sts., Pittsburgh, Pa. 15203; and Research and Development Division, Worthington Biochemical Corp., Freehold, N.J. 07728.

We describe the use of sodium thymolphthalein monophosphate as a substrate for measuring acid phosphatase activity in serum. Thymolphthalein is liberated in the reaction and is conveniently measured by increasing the pH of the medium, which produces a color and also stops the hydrolysis. Optimal conditions for enzymatic activity were defined for use in the final assay system. Purified acid phosphatase isoenzymes from various human tissues and sera from patients with nonprostatic diseases most likely to affect serum acid phosphatase activity were used to show that the new method is more specific for the prostatic enzyme than other commonly used procedures for acid phosphatase. Other advantages include simplicity, good sensitivity over a wide range of activity, high precision, zero-order kinetics to about 200 times the upper limit of normal, easy standardization by a pure standard, and reagent stability.


Key Words: specificity of various substrates compared • optimal conditions • inhibitors • clinical studies • relative activities of enzyme from various (human) sources

Submitted on March 30, 1971
Accepted on June 23, 1971




The following articles in journals at HighWire Press have cited this article:


Home page
 Cancer Res.Home page
P. Pospisil, K. Wang, A. F. Al Aowad, L. K. Iyer, S. J. Adelstein, and A. I. Kassis
Computational Modeling and Experimental Evaluation of a Novel Prodrug for Targeting the Extracellular Space of Prostate Tumors
Cancer Res., March 1, 2007; 67(5): 2197 - 2205.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. A. Pettaway, L. L. Pisters, P. Troncoso, J. Slaton, L. Finn, K. Kamoi, and C. J. Logothetis
Neoadjuvant Chemotherapy and Hormonal Therapy Followed by Radical Prostatectomy: Feasibility and Preliminary Results
J. Clin. Oncol., March 1, 2000; 18(5): 1050 - 1050.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. W. LaCount, G. Handy, and L. Lebioda
Structural Origins of L(+)-Tartrate Inhibition of Human Prostatic Acid Phosphatase
J. Biol. Chem., November 13, 1998; 273(46): 30406 - 30409.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1971 by the American Association for Clinical Chemistry.